Compare Remala Abadi Tbk. (DATA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remala Abadi Tbk. vs Merck Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp1,890 (market cap 2.64T, 655.7K 24h volume), while Merck Tbk. trades at Rp3,910 (market cap 1.79T, 28.4K 24h volume). The key difference: Remala Abadi Tbk. is the larger of the two by market cap, and Remala Abadi Tbk. is more actively traded (655.7K versus 28.4K). Which is the better fit depends on your goals.
| DATA | MERK | |
|---|---|---|
Market Cap | 2.64T | 1.79T |
Volume | 655.7K | 28.4K |
Lot | 6.56K | 284 |
Turnover | 1.24B | 111.11M |
Average Price | 1,885.23 | 3,912.29 |
Value | 1.24B | 111.11M |
Indicative Equilibrium Price | 1,890 | 3,910 |
Indicative Equilibrium Volume | 116 | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Remala Abadi Tbk.
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
